Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

102 trials

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT00712933
What this trial is testing

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 738
Testing effectiveness (Phase 2)Ended earlyNCT00732940
What this trial is testing

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 56
Post-approval studies (Phase 4)UnknownNCT04893161
What this trial is testing

A Model About the Response of Belimumab in SLE

Who this might be right for
Systemic Lupus Erythematosus
First Affiliated Hospital Xi'an Jiaotong University 72
Testing effectiveness (Phase 2)Study completedNCT01160666
What this trial is testing

Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Assistance Publique - Hôpitaux de Paris 20
Not applicableLooking for participantsNCT06527872
What this trial is testing

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Who this might be right for
Lupus Nephritis
GlaxoSmithKline 300
Large-scale testing (Phase 3)UnknownNCT05863936
What this trial is testing

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

Who this might be right for
Lupus NephritisRemissionSafety Issues
Nanjing University School of Medicine 15
Not applicableNot Yet RecruitingNCT04671706
What this trial is testing

Belimumab in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina 3,000
Post-approval studies (Phase 4)UnknownNCT04447053
What this trial is testing

Sequential Belimumab and T-cell Based Therapy in SLE

Who this might be right for
Systemic Lupus Erythematosus
National University Hospital, Singapore 80
Not applicableUnknownNCT05659407
What this trial is testing

BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisBLyS Polymorphism
University of Cagliari 60
Testing effectiveness (Phase 2)Ended earlyNCT00583557
What this trial is testing

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Who this might be right for
Rheumatoid Arthritis
Human Genome Sciences Inc. 155
Post-approval studies (Phase 4)Study completedNCT01597492
What this trial is testing

Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 79
Post-approval studies (Phase 4)Study completedNCT01632241
What this trial is testing

Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 503
Large-scale testing (Phase 3)Study completedNCT02347891
What this trial is testing

Belimumab in Idiopathic Inflammatory Myositis

Who this might be right for
Myositis
Northwell Health 17
Post-approval studies (Phase 4)Study completedNCT01705977
What this trial is testing

Belimumab Assessment of Safety in SLE

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 4,019
Post-approval studies (Phase 4)Looking for participantsNCT06410833
What this trial is testing

Belimumab After Rituximab in Resistant Primary Juvenile SS

Who this might be right for
Sjogren's SyndromePediatric ALL
Peking Union Medical College Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02260934
What this trial is testing

Rituximab and Belimumab for Lupus Nephritis

Who this might be right for
Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 43
Not applicableStudy completedNCT01914770
What this trial is testing

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1,016
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation